Literature DB >> 2180844

Distribution of transthyretin in the rat eye.

A J Dwork1, T Cavallaro, R L Martone, D S Goodman, E A Schon, J Herbert.   

Abstract

We reported previously synthesis of transthyretin (TTR), or prealbumin, a transport protein for thyroxine and retinol, in the eyes of rats and cows and showed that in the rat eye, TTR mRNA is localized exclusively in the retinal pigment epithelium (RPE). We now demonstrate by immunohistochemistry that TTR has a more widespread distribution in the rat eye than does its mRNA. Intense immunoreactivity for TTR was found in the RPE, ciliary epithelium, iris epithelium, corneal endothelium, optic nerve fiber layer of the retina, and lens capsule. Depending on the method of processing, immunoreactivity of varying intensity was found also in other ocular structures. In particular, the retinal ganglion cells were strongly immunoreactive on frozen sections but not on paraffin sections. Although vitreous humor was not included in the sections of adult rat eye, sections of a 25-mm rat embryo showed intense immunoreactivity in the vitreous humor. Since plasma TTR does not cross Bruch's membrane into the retina, our findings suggest that ocular TTR is synthesized, at least in part, in the RPE and is transported to specific locations within the eye. Although the physiologic role of ocular TTR is unknown, it is possible that it participates in retinol cycling within the eye. The widespread ocular distribution of TTR may account for the occurrence of various forms of ocular amyloidosis in the familial amyloidotic polyneuropathies, a group of dominantly inherited disorders caused by point mutations in the TTR gene.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2180844

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  15 in total

1.  Distribution of lead and transthyretin in human eyes.

Authors:  J W Eichenbaum; W Zheng
Journal:  J Toxicol Clin Toxicol       Date:  2000

2.  Ophthalmic manifestations in a Chinese family with familial amyloid polyneuropathy due to a TTR Gly83Arg mutation.

Authors:  T Liu; B Zhang; X Jin; W Wang; J Lee; J Li; H Yuan; X Cheng
Journal:  Eye (Lond)       Date:  2013-10-11       Impact factor: 3.775

3.  Generating iPSC-Derived Choroidal Endothelial Cells to Study Age-Related Macular Degeneration.

Authors:  Allison E Songstad; Luke A Wiley; Khahn Duong; Emily Kaalberg; Miles J Flamme-Wiese; Cathryn M Cranston; Megan J Riker; Dana Levasseur; Edwin M Stone; Robert F Mullins; Budd A Tucker
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-12       Impact factor: 4.799

4.  Multimodal retinal imaging in a Chinese kindred with familial amyloid polyneuropathy secondary to transthyretin Ile107Met mutation.

Authors:  W Lv; J Chen; W Chen; P Hou; C P Pang; H Chen
Journal:  Eye (Lond)       Date:  2014-01-31       Impact factor: 3.775

5.  Use of a 13C tracer to investigate lutein as a ligand for plasma transthyretin in humans.

Authors:  Liwei Chen; Xixuan Hu Collins; Louisa B Tabatabai; Wendy S White
Journal:  Lipids       Date:  2005-10       Impact factor: 1.880

6.  A marker for primary choroid plexus neoplasms.

Authors:  J Herbert; T Cavallaro; A J Dwork
Journal:  Am J Pathol       Date:  1990-06       Impact factor: 4.307

7.  Cerebrospinal fluid and vitreous body exposure to orally administered tafamidis in hereditary ATTRV30M (p.TTRV50M) amyloidosis patients.

Authors:  Cecilia Monteiro; Ana Martins da Silva; Natália Ferreira; Jaleh Mesgarzadeh; Marta Novais; Teresa Coelho; Jeffery W Kelly
Journal:  Amyloid       Date:  2018-07-11       Impact factor: 7.141

8.  Ophthalmological manifestations in hereditary transthyretin (ATTR V30M) carriers: a review of 513 cases.

Authors:  João Melo Beirão; Jorge Malheiro; Carolina Lemos; Idalina Beirão; Paulo Costa; Paulo Torres
Journal:  Amyloid       Date:  2015-06-22       Impact factor: 7.141

9.  Transthyretin and complex protein pattern in aqueous humor of patients with primary open-angle glaucoma.

Authors:  F H Grus; S C Joachim; S Sandmann; U Thiel; K Bruns; K J Lackner; N Pfeiffer
Journal:  Mol Vis       Date:  2008-08-04       Impact factor: 2.367

10.  Is Transthyretin a Regulator of Ubc9 SUMOylation?

Authors:  Elżbieta Wieczorek; Sylwia Kędracka-Krok; Katarzyna Sołtys; Urszula Jankowska; Rafał Hołubowicz; Justyna Seliga; Andrzej Ożyhar
Journal:  PLoS One       Date:  2016-08-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.